Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NIH report throws water on CRADAs as source of funds

WASHINGTON - A recently released report on NIH's Intramural Research Program calls for streamlining the institutes' technology transfer procedures and questions the utility of the "reasonable pricing" clause in CRADAs.

The NIH commissioned the report in response to a congressional

Read the full 400 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE